Amgen
Tezspire
Manufacturer:
Amgen
Name:
Tezspire
HCPCS Code Descriptor:
Injection, tezepelumab-ekko, 1 mg
Category:
J Code
HCPCS:
J2356
NDC(s):
55513-0123-01, 55513-0112-01
Primary Type:
Anti-Eosinophil Asthma
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
Tezspire is an Anti-Eosinophil Asthma drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J2356 is aligned to the drug Tezspire.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/22
HCPCS Effective Date:
7/1/22
HCPCS Short Description:
Inj tezepelumab-ekko, 1mg
Billing and Coding Guide:
https://www.tezspirehcp.com/content/dam/open-digital/tezspirehcpday1/en/pdf/TEZSPIRE_Billing_and_Coding_Guide.pdf?source=TZP_N_H_2284&umedium=cpc&uadpub=GOOGLE&ucampaign=USA_GO_SEM_HCP_B_PH_Brand-Tezspire&ucreative=Core&uplace=tezspire&outcome=HCP&cmpid=1&cid=PPC-accountype:GOOGLE-campaign:USA_GO_SEM_HCP_B_PH_Brand-Tezspire-searchterm:tezspire-adgroup:Core-keywordid:p68215832627&us_privacy=${us_privacy}&gclsrc=aw.ds&
Patient Assistance:
https://www.tezspire.com/savings-and-support.html